FDA okays Viatris' insulin drug as first 'interchangeable' b...

Generic drugmaker Viatris has become the first company to secure FDA approval for a biosimilar product that is considered completely interchangeable with the reference product – namely Sano

Sanofi builds case for Toujeo in younger type 1 diabetics

Mylan’s Lantus biosimilar held up by manufacturing issue

Sanofi beats expectations, driven by rare diseases and vacci...

But sales of key insulin fall amid biosimilar competition.